Liquidia (LQDA) Change in Account Payables (2020 - 2026)
Liquidia (LQDA) recorded quarterly Change in Account Payables of $562000.0 in Q1 2026, up 128.62% quarter-over-quarter from -$2.0 million in Q4 2025, and down 83.56% on a YoY basis from $3.4 million in Q1 2025.
Liquidia (LQDA) Change in Account Payables (2020 - 2026) Analysis & Trends
Liquidia's Change in Account Payables history runs 7 years deep, the most recent figure standing at $562000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 83.56% year-over-year to $562000.0; the TTM figure through Mar 2026 stood at -$5.4 million (down 200.07% YoY), while the FY2025 annual figure was -$2.6 million, down 211.29% from the prior year.
- Change in Account Payables was $562000.0 for Q1 2026 at Liquidia, up from -$2.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.4 million in Q1 2025 to a low of -$6.0 million in Q3 2025.
- Historically, Change in Account Payables has averaged -$2294.1 across 5 years, with a median of $303000.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables slumped 1857.95% in 2024, then jumped 1028.05% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $1.0 million in 2022, then sank by 158.6% to -$596000.0 in 2023, then surged by 528.19% to $2.6 million in 2024, then sank by 176.96% to -$2.0 million in 2025, then jumped by 128.62% to $562000.0 in 2026.
- The last three Change in Account Payables figures came in at $562000.0 (Q1 2026), -$2.0 million (Q4 2025), and -$6.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 190,000.00 |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 167.64 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 562,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 562,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Dec 31, 2025 | -1.96 Mn |
| Dec 31, 2025 | -1.96 Mn |
| Sep 30, 2025 | -5.99 Mn |
| Sep 30, 2025 | -5.99 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 2.55 Mn |
| Dec 31, 2024 | 2.55 Mn |
| Sep 30, 2024 | -3.45 Mn |
| Sep 30, 2024 | -3.45 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Mar 31, 2024 | 303,000.00 |
| Mar 31, 2024 | 303,000.00 |
| Dec 31, 2023 | -596,000.00 |
| Dec 31, 2023 | -596,000.00 |